Piramal Pharma gets EIR for manufacturing facility in USA

09 Nov 2023 Evaluate

Piramal Pharma has received an Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for the manufacturing facility located at Bethlehem, USA and the inspection has now been successfully closed by the USFDA.

Piramal Pharma provides end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.


Piramal Pharma Share Price

174.20 -2.90 (-1.64%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×